Janux Therapeutics(NASDAQ:JANX) 
Janux Therapeutics is an innovative clinical-stage biopharmaceutical company developing next-generation therapeutics based on applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms to better treat patients suffering f...
Website: https://www.januxrx.com/
Founded: 2017
IPO Price: $17 (Jun 11, 2021)
CEO: David Campbell
Sector:
Industry:
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 26.22
H 26.25
L 24.30
C 25.77
V 831,353
10EMA 25.77
20EMA 25.77
60EMA 25.77
120EMA 25.77
250EMA 25.77